Senior Leadership Team

Lee Ferreira joined Ferring Canada as General Manager in September 2017.

Lee has close to 30 years experience in the Pharma-Biotech Industry.  In fact, it was Ferring Canada that gave Lee her first opportunity into the industry in early 1990 when she joined the company as a Clinical Research Associate following the completion of her post graduate degree.  She has certainly come full circle and is incredibly proud to be leading the team here in Canada. 

Prior to Ferring, Lee held the role of President and CEO of LEO Pharma and CEO of Medical Futures, as well as various roles with Sanofi-Genzyme, Roche and Solvay Pharma. She has had enormous opportunities to broaden her level of expertise and develop as a senior leader in various areas including Clinical Research, Market Access, Marketing, Sales and Business Unit Management.  Her therapeutic areas of knowledge include fertility and woman’s health, gastroenterology, urology, neurology, nephrology and dermatology.

Lee holds a Master of Science degree in Anatomy Physiology and a Bachelor of Science degree from the University of Toronto.

Sumintra Singh joined Ferring Canada as Financing Planning Manager in 2003 and is now Senior Director Finance, Logistics and IT. 

Sumintra has expertise as a financial business partner to deliver analysis, execution and bottom-line results. She is accountable for all aspects of the company financial reporting and is a strategic business partner to the management team and operational business units. She worked in both the pharmaceutical industry and the consumer goods industry. 

Sumintra Singh is a CPA, CGA and holds  H.B. Com from Laurentian University.

Sue Elliott’s journey with Ferring Canada began in January 2019, and over the past four years, she has exhibited dedication and leadership through progressive roles within the Medical Affairs Team. On August 1, 2023, Sue was appointed Medical Director.

Sue is a key contributor to forging strong strategic external stakeholder relationships with Key Opinion Leaders (KOLs), healthcare providers, patient associations, and clinical investigators.

Prior to Ferring, Sue played a vital role as the Scientific Development Manager at Grifols Canada Inc. and before Grifols, co- founded Virtus Insights Inc., where she provided strategic management services for small-to-medium-sized organizations, with a focus on early-stage commercialization and life science ventures.

Sue's impressive educational background includes an MBA from Queen's University with a specialization in Marketing and Financing of New Ventures. She also holds a PhD in Gastrointestinal Sciences from the University of Calgary and has completed a post-doctoral research fellowship in GI Immunology at the University of Virginia and the University of Texas Medical Branch.

Lucas Schmid was appointed HR Director at Ferring Canada in January 2024.

Lucas' journey with Ferring started in 2014 when he joined the Ferring Swiss Manufacturing Plant located in St.Prex, Switzerland. In 2017, Lucas moved to the HR position for the Headquarters where he continued to develop a vast experience in HR with strong global interactions across geographies and stakeholders. He transferred to Canada from his role as Director, HRBP HQ and Ferring Ventures, in which he has delivered an active partnership to HQ leaders and certain global functions, providing advice and support to leaders in organizational development and HR management. Prior to his time at Ferring, Lucas built his track record in local HR operations in international and pharmaceutical companies.

Lucas brings to Canada a combination of skills in strategic HR management, talent management, employee relations, change and stakeholder management. In his new role, Lucas will advise the leadership team about HR strategies and management, to continue Canada’s ongoing journey enabling talent and organizational development in the market.

Rob White has been appointed Director of Market Access and Pricing for Ferring Canada on July 2, 2024. As of September 1st, 2024, Rob has also taken the leadership of Business Intelligence and Sales Operations. 

Rob brings with him a wealth of experience and expertise in market access, payer negotiations, strategic pricing, finance, supply chain and operations from his tenure at GlaxoSmithKline. 

At GlaxoSmithKline, Rob held pivotal roles as Director of Market Access & Payer Strategy and Director of Pricing and Payer Strategy, where he demonstrated leadership in securing access and reimbursement for various portfolios. He successfully led negotiations with national payers, resulting in favorable pricing terms and accelerated timelines for product contracts. His track record of exceeding expectations, optimizing pricing strategies, and driving performance will undoubtedly contribute to our continued success at Ferring.

Rob is a Chartered Global Management Accountant (CGMA) and has Bachelor of Science Degree in Finance.